AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Dr Reddy's net profit plummets 62.74% to Rup 389.3 M for 2Q 2004-2005.
(From Chemical Business NewsBase - Business Line)
Dr Reddy's Laboratories Ltd (Dr Reddy's) posted a 62.74% lower net profit at Rup 389.3 M on a turnover of Rup 4535.1 M for 2Q ended Sep 2004 (net profit of Rup 1045.1 M on a turnover of Rup 4721.8 M in 2Q ended Sep 2003), as per Indian GAAP financials. The company derived revenues of Rup 1786.3 M from active pharmaceutical ingredients and intermediates, Rup 601.6 M from generics and Rup 200,000 from drug discovery for 2Q 2004-2005 (revenues of Rup 2088 M form active pharmaceutical ingredients and intermediates, Rup 625.4 M from generics and Rup …
-
- DSCL: 3Q 2002-2003 net profit up at Rup 123.1 M. [2 tables].
-
News wire article from: Asia Africa Intelligence Wire
January 31, 2003
700+ words
-
- Dr Reddy's: 1Q 2003-2004 net profit at Rup 1235.1 M. [3 tables].
-
News wire article from: Asia Africa Intelligence Wire
August 1, 2003
700+ words
-
- Lupin posts Rup 950 M net profit for 2003-2004.
-
News wire article from: Asia Africa Intelligence Wire
April 29, 2004
700+ words
-
- Grasim 2Q 2003-2004 net profit zooms 58% to Rup 2.02 bn.
-
News wire article from: Asia Africa Intelligence Wire
October 24, 2003
700+ words
-
- Jubilant Organosys: 2Q 2002-2003 net profit after tax at Rup 129 M. [2 tables].
-
News wire article from: Asia Africa Intelligence Wire
October 24, 2002
700+ words
